Orchestra BioMed Holdings, Inc.
OBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61,024 | -$49,120 | -$33,608 | -$23,014 |
| Dep. & Amort. | $308 | $287 | $222 | $181 |
| Deferred Tax | $0 | $0 | $0 | $288 |
| Stock-Based Comp. | $10,615 | $7,625 | $3,413 | $302 |
| Change in WC | -$765 | -$3,307 | -$451 | $2,597 |
| Other Non-Cash | $308 | -$1,612 | $1,135 | $217 |
| Operating Cash Flow | -$50,558 | -$46,127 | -$29,289 | -$19,429 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$289 | -$78 | -$591 | -$274 |
| Net Acquisitions | -$602 | $0 | $0 | -$13,291 |
| Inv. Purchases | -$72,648 | -$142,032 | -$63,531 | -$213 |
| Inv. Sales/Matur. | $86,628 | $152,797 | $0 | $13,504 |
| Other Inv. Act. | $0 | $0 | $0 | $13,291 |
| Investing Cash Flow | $13,089 | $10,687 | -$64,122 | $13,017 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $15,000 | -$10,849 | $3,554 | -$4,000 |
| Stock Issued | $15,035 | $254 | $109,830 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$864 | $56,810 | -$10,127 | $7 |
| Financing Cash Flow | $29,171 | $46,215 | $103,257 | -$3,993 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8,298 | $10,775 | $9,846 | -$10,405 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30,559 | $19,784 | $9,938 | $20,343 |
| End Cash | $22,261 | $30,559 | $19,784 | $9,938 |
| Free Cash Flow | -$50,847 | -$46,205 | -$29,880 | -$19,703 |